| __timestamp | Bristol-Myers Squibb Company | Dynavax Technologies Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 15879000000 | 11032000 |
| Thursday, January 1, 2015 | 16560000000 | 4050000 |
| Friday, January 1, 2016 | 19427000000 | 11043000 |
| Sunday, January 1, 2017 | 20776000000 | 327000 |
| Monday, January 1, 2018 | 22561000000 | 8198000 |
| Tuesday, January 1, 2019 | 26145000000 | 35219000 |
| Wednesday, January 1, 2020 | 42518000000 | 46551000 |
| Friday, January 1, 2021 | 46385000000 | 439442000 |
| Saturday, January 1, 2022 | 46159000000 | 722683000 |
| Sunday, January 1, 2023 | 45006000000 | 232284000 |
| Monday, January 1, 2024 | 48300000000 |
Data in motion
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success and market influence. Over the past decade, Bristol-Myers Squibb Company and Dynavax Technologies Corporation have showcased contrasting trajectories in their annual revenue growth.
Bristol-Myers Squibb, a stalwart in the pharmaceutical industry, has seen its revenue more than double from 2014 to 2023, peaking in 2021 with a remarkable 192% increase compared to 2014. This growth underscores its strategic acquisitions and robust product pipeline.
Conversely, Dynavax Technologies, a smaller player, experienced a meteoric rise in revenue, especially between 2020 and 2022, where it surged by over 1,500%. This leap highlights Dynavax's successful ventures into vaccine development, particularly during the global health crisis.
These trends reflect the broader shifts in the biotech landscape, where innovation and strategic positioning are paramount.
Who Generates More Revenue? AbbVie Inc. or Bristol-Myers Squibb Company
Revenue Insights: Merck & Co., Inc. and Bristol-Myers Squibb Company Performance Compared
Bristol-Myers Squibb Company and Gilead Sciences, Inc.: A Comprehensive Revenue Analysis
Revenue Showdown: Bristol-Myers Squibb Company vs United Therapeutics Corporation
Breaking Down Revenue Trends: Bristol-Myers Squibb Company vs Exelixis, Inc.
Bristol-Myers Squibb Company and Jazz Pharmaceuticals plc: A Comprehensive Revenue Analysis
Bristol-Myers Squibb Company vs Telix Pharmaceuticals Limited: Annual Revenue Growth Compared
Annual Revenue Comparison: Bristol-Myers Squibb Company vs Taro Pharmaceutical Industries Ltd.
Genmab A/S and Dynavax Technologies Corporation: A Comprehensive Revenue Analysis
Viatris Inc. vs Dynavax Technologies Corporation: Examining Key Revenue Metrics
Comparing Revenue Performance: Corcept Therapeutics Incorporated or Dynavax Technologies Corporation?
Annual Revenue Comparison: Dynavax Technologies Corporation vs Celldex Therapeutics, Inc.